Literature DB >> 11679022

Neopterin measurement in clinical diagnosis.

A Berdowska1, K Zwirska-Korczala.   

Abstract

Neopterin is a marker associated with cell-mediated immunity. It is produced in monocytes/macrophages primarily upon stimulation with interferon-gamma. Due to its chemical structure, neopterin belongs to the class of pteridines. It is excreted in an unchanged form via the kidneys. Serum levels above 10 nmol/L are regarded as elevated. The levels of neopterin in body fluids are elevated in infections, autoimmune diseases, malignancies, allograft rejection, cardiac and renal failure, coronary artery disease and myocardial infarction. Neopterin measurements not only provide an insight into the present state of cell-mediated immune response but also allow monitoring and prognosis of disease progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679022     DOI: 10.1046/j.1365-2710.2001.00358.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  53 in total

1.  Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.

Authors:  Sean X Leng; Huifen Li; Qian-Li Xue; Jing Tian; Xi Yang; Luigi Ferrucci; Neal Fedarko; Linda P Fried; Richard D Semba
Journal:  Exp Gerontol       Date:  2011-04-13       Impact factor: 4.032

2.  Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography.

Authors:  C Özbek; I Baran; A Tütüncü; T Kuştarcı; K Karaağaç; A Özbek
Journal:  Ir J Med Sci       Date:  2013-08-29       Impact factor: 1.568

3.  High levels of neopterin and interleukin-3 in sickle cell disease patients.

Authors:  L Rodrigues; F F Costa; S T O Saad; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Sorting through new biomarkers.

Authors:  Frances O Wood; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

5.  Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat.

Authors:  Monique E Spencer; Alka Jain; Amy Matteini; Brock A Beamer; Nae-Yuh Wang; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-17       Impact factor: 6.053

6.  Sleep onset insomnia, daytime sleepiness and sleep duration in relationship to Toxoplasma gondii IgG seropositivity and serointensity.

Authors:  Zaki Ahmad; Yara W Moustafa; John W Stiller; Mary A Pavlovich; Uttam K Raheja; Claudia Gragnoli; Soren Snitker; Sarra Nazem; Aline Dagdag; Beverly Fang; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-28       Impact factor: 0.581

7.  Seasonality of blood neopterin levels in the Old Order Amish.

Authors:  Hira Mohyuddin; Polymnia Georgiou; Abhishek Wadhawan; Melanie L Daue; Lisa A Brenner; Claudia Gragnoli; Erika F H Saunders; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache
Journal:  Pteridines       Date:  2017-12-02       Impact factor: 0.581

8.  Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.

Authors:  Ou Jin; Ling-yun Sun; Kang-xin Zhou; Xin-su Zhang; Xue-bing Feng; Mo-yin Mok; Chak-sing Lau
Journal:  Clin Rheumatol       Date:  2004-07-28       Impact factor: 2.980

9.  Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease.

Authors:  Hiroshi Ichinose; Ken-Ichi Inoue; Shinobu Arakawa; Yuki Watanabe; Hiroki Kurosaki; Shoko Koshiba; Eldbjorg Hustad; Masahiko Takada; Jan O Aasly
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

10.  Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines.

Authors:  Ceren Cıralı; Emel Ulusoy; Tuncay Kume; Nur Arslan
Journal:  World J Pediatr       Date:  2018-03-16       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.